Literature DB >> 2600427

Heat inactivation of serum potentiates anti-cardiolipin antibody binding in ELISA.

H M Cheng1, Y F Ngeow, C K Sam.   

Abstract

Heat treatment of sera at 56 degrees C for 30 min results in positive ELISA reactions for anti-cardiolipin antibody (aCL) in sera that had undetectable or low levels of aCL before heat inactivation. The positive, potentiated reactivity of the heated sera in the aCL ELISA could be inhibited with the cardiolipin antigen and was abolished by prior IgG depletion using staphylococcal protein A. The heat-potentiating effect of aCL binding in ELISA was evident in both normal human sera and clinical sera including sera from patients with systemic lupus erythematosus and syphilis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2600427     DOI: 10.1016/0022-1759(89)90359-1

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  4 in total

1.  Anti-endothelial cell antibodies in systemic vasculitis and systemic lupus erythematosus (SLE): effects of heat inactivation on binding and specificity.

Authors:  D P D'Cruz; G Keser; H Direskeneli; M A Khamashta; G R Hughes
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

2.  Heat treatment of normal human sera reveals antibodies to bactericidal permeability-inducing protein (BPI).

Authors:  A A Brownlee; C M Lockwood
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

3.  Complement factor D, albumin, and immunoglobulin G anti-band 3 protein antibodies mimic serum in promoting rosetting of malaria-infected red blood cells.

Authors:  Alexander Luginbühl; Milica Nikolic; Hans Peter Beck; Mats Wahlgren; Hans U Lutz
Journal:  Infect Immun       Date:  2007-01-29       Impact factor: 3.441

4.  Natural hidden autoantibodies to tissue transglutaminase cross-react with fibrinogen.

Authors:  Ingrid M Zöller-Utz; Birgit Esslinger; Anja Schulze-Krebs; Walburga Dieterich
Journal:  J Clin Immunol       Date:  2009-11-27       Impact factor: 8.317

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.